You searched for Switzerland

News and Trends 24 Apr 2020

Big €10M Seed Round Funds New Class of Cancer Drugs in Switzerland

The Swiss biotech FoRx Therapeutics has raised an impressive €10M in seed funding to develop a new generation of drugs that target DNA repair in cancer cells. The drugs will block a DNA repair process called break-induced replication, which was discovered by the company’s scientific founder Thanos Halazonetis. This process is used by cancer cells […]

April 24, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 21 Aug 2017

First-in-Human Trial will test a New Cancer Therapy from Switzerland

Cellestia Biotech will start human trials with CB-103, an anticancer drug targeting the Notch signaling pathway, known for its ubiquity in cancer. Cellestia Biotech, based in Basel, has announced it received full approval to start clinical trials in Spain with CB-103, a new class of drug that targets an ubiquitous cancer mechanism. The drug is a […]

August 21, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Screenshot 2017 01 27 at 2.17.05 PM 1 e1485524200727

Startup Scout 27 Jan 2017

Needle-free Treatments for Autoimmune Disorders from Switzerland

It’s back to go back to the mainland. This week’s stop is in Hergiswill, a city by one of the many beautiful seas that can be found in Switzerland. There, the young biotech BioLingus is developing needle-free therapies for chronic diseases. City: Hergiswill, Switzerland Founded: 2014 Employees: 1-10 Financial data: N/A Mission: BioLingus develops non-invasive treatments for autoimmune and inflammatory […]

January 27, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Screenshot 2016 12 16 at 10.46.56 AM 1 e1481881804814

News and Trends 16 Dec 2016

Mini-Organs grown in Switzerland are Here to Change Drug Discovery

This week we travel to Lausanne, a thriving biotech hub in Switzerland. Here, QGel is working to replicate the complexity of life in vitro in lab-grown mini-organs to improve drug discovery. Cool, right? City: Lausanne, Switzerland Founded: 2009 Employees: 11-50 Financial data: Total of €12M raised (12/2016) Mission: QGel creates personalized arrays that can mimic the cellular architecture of different organs. […]

December 16, 2016 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 8 Dec 2016

Meet the Newest ALS Pioneer Company from Switzerland

AL-S Pharma was just born with the only purpose of developing a drug candidate for ALS, a rare condition for which no effective treatments exist. The parents of the newborn company are Neurimmune, a biotech from Zurich that uses high throughput technology to develop treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s, and TVM Capital Life Science. […]

December 8, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Jul 2016

Switzerland discovers Pomegranate ‘Anti-Ageing’ Effect and founds Biotech

Researchers at the École Polytechnique Fédérale de Lausanne (EPFL) have uncovered a molecule in the pomegranate fruit which can prolong the lifespan of animal models. The co-authors who published in Nature went to co-found a biotech Amazentis to develop the wonder molecule into clinical trials. There are many underlying factors to what happens to our bodies as we age. However, […]

July 18, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 4 Apr 2016

Allergy Immunotherapy from Switzerland gets several Million in funding

Anergis (Switzerland) has gotten €4.5M from investors and is planning a phase IIb trial for ATIBAR, its leading candidate to treat Tree allergies. Anergis is developing ultra-fast immunotherapies for allergies, which could be an interesting alternative to current treatments, known as ‘desensitization’ or conventional Allergy Immunotherapy (AIT). This process of inducing tolerance to the allergen requires 3-5 […]

April 4, 2016 - 2 minutesmins - By Denise Neves Gameiro

karolinska microbiome ferring pharma research scilifelab

News and Trends 28 Jan 2016

Sweden and Switzerland Join in on Microbiome Hype with New Karolinska Research Centre

Ferring Pharmaceuticals (Switzerland) and the Karolinska Institutet (Sweden) announce a collaboration on a new research centere exploiting the human microbiome. The Karolinska Institutet has a deep understanding of the human microbiome, and the institute actually accounts for over 40% of the medical academic research conducted in Sweden (not to mention their long-standing ties with the Nobel Prize […]

January 28, 2016 - 2 minutesmins - By Dani Bancroft

In Depth 7 Mar 2024

Can AbbVie’s legacy live beyond its once best-selling drug Humira?

The sales of AbbVie’s Humira, once a best-seller, have dropped. Now, with a new CEO announced, things are about to change for the company.

March 7, 2024 - 8 minutesmins - By Roohi Mariam Peter

Biotech deals partnerships and MA tracker

2024 biotech deals tracker: the latest partnerships and M&A

Explore the pulse of biotech deals on our dedicated page, featuring only the most notable news sorted by top pharmaceutical companies and by month. We meticulously curate and categorize the latest collaborations and M&A activities, ensuring you stay informed about the most significant trends and strategic moves shaping the industry. Would you like to receive […]

March 7, 2024 - 1 minutemin - By Aurore Michelin

Best in Biotech 5 Mar 2024

Fourteen biotech companies with market caps exceeding $100 billion

Discover the biotech leaders with a market capitalization exceeding $100 billion, driving innovation and shaping tomorrow’s breakthroughs.

March 5, 2024 - 18 minutesmins - By Jules Adam

2024 biotech funding tracker: recent highlights

Discover the latest in biotech funding on our dedicated page. We meticulously curate and categorize significant fundraising events to keep you informed about the cutting-edge trends and investments driving the industry forward. Explore our tracker organized chronologically and by funding method, providing a comprehensive perspective on the ever-evolving world of biotech fundraising. Would you like […]

February 23, 2024 - 1 minutemin - By Aurore Michelin

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us